3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Breast
1
Conditions
Ventricular Dysfunction, Left
1
Lymphoma, Large B-Cell, Diffuse
1
Cardiotoxicity
1
Breast Neoplasms
1
Interventions
Doxorubicin
6
Vincristine
4
Dexrazoxane
4
Razoxane
3
Radiotherapy
2
Prednisone
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Exercise
2
Etoposide
2
Cyclophosphamide
2
Bleomycin
2
pegfilgrastim
1
hydrocortisone hemisuccinate
1
Vascular Stiffness
1
VAP-cyclo protocol
1
Secondary Prevention
1
Rituximab
1
Pulse Wave Analysis
1
Prednisolone
1
Nebivolol
1
Methotrexate
1
Methods
1
Mercaptopurine
1
Leucovorin
1
Lenalidomide
1
Hydrocortisone
1
Electrocardiography
1
Echocardiography
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Nebivolol
×
Lymphoid
×
Clear all
NCT05728632
2023-02-23
CONTROL
Humanitas Hospital, Italy
Phase 3
Unknown
80 enrolled